| Literature DB >> 26019342 |
Sudhir Sivakumaran1, Ross A Cardarelli2, Jamie Maguire3, Matt R Kelley3, Liliya Silayeva2, Danielle H Morrow3, Jayanta Mukherjee2, Yvonne E Moore3, Robert J Mather4, Mark E Duggan4, Nicholas J Brandon4, John Dunlop4, Stephen Zicha4, Stephen J Moss5, Tarek Z Deeb6.
Abstract
GABA(A) receptors form Cl(-) permeable channels that mediate the majority of fast synaptic inhibition in the brain. The K(+)/Cl(-) cotransporter KCC2 is the main mechanism by which neurons establish low intracellular Cl(-) levels, which is thought to enable GABAergic inhibitory control of neuronal activity. However, the widely used KCC2 inhibitor furosemide is nonselective with antiseizure efficacy in slices and in vivo, leading to a conflicting scheme of how KCC2 influences GABAergic control of neuronal synchronization. Here we used the selective KCC2 inhibitor VU0463271 [N-cyclopropyl-N-(4-methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]acetamide] to investigate the influence of KCC2 function. Application of VU0463271 caused a reversible depolarizing shift in E(GABA) values and increased spiking of cultured hippocampal neurons. Application of VU0463271 to mouse hippocampal slices under low-Mg(2+) conditions induced unremitting recurrent epileptiform discharges. Finally, microinfusion of VU0463271 alone directly into the mouse dorsal hippocampus rapidly caused epileptiform discharges. Our findings indicated that KCC2 function was a critical inhibitory factor ex vivo and in vivo.Entities:
Keywords: GABAA; KCC2; VU0463271; chloride; seizures; slices
Mesh:
Substances:
Year: 2015 PMID: 26019342 PMCID: PMC4444547 DOI: 10.1523/JNEUROSCI.5205-14.2015
Source DB: PubMed Journal: J Neurosci ISSN: 0270-6474 Impact factor: 6.167